MedeSol Global, Inc. deploys proprietary hypochlorous acid technology to improve human health and hygiene around the world — replacing a generation of toxic disinfectants with a molecule the human body has trusted since the dawn of life.
25+ years in chlorine chemistry, finance, and operations; executed an $80M London Stock Exchange IPO. MBA, University of Washington (Foster).
200+ peer-reviewed publications and 30 patents; PhD (UPenn), Fulbright Scholar, AAAS Fellow; principal architect of the WHO Essential Medicines applications. Former CSO of Briotech and HaloSource.
Serial entrepreneur and co-founder of HaloSource; 35 years in healthcare and specialty materials; 7 U.S. patents; U.S. Army combat veteran.
25+ years in dental and medical sales; former senior executive at Kerr/Metrex (Danaher); led global operations for CaviCide.
Microbiologist and founder of Force of Nature — the first EPA-registered consumer HOCl product.
21+ HOCl publications; co-inventor on two U.S. patent applications; NIH- and NSF-funded.
AV Preeminent® rated (top 1%); former general counsel to NYSE-listed companies; M&A experience across 12+ countries.
Our HOCl is manufactured under a 15-year exclusive agreement at Alden Medical’s FDA-registered, EPA-compliant facility in West Springfield, Massachusetts — on a transparent, audited model. Alden is also a strategic investor with a seat on our board.
Dr. Jeffrey Williams · Joshua Johnston · Simon Johnston · Damon D’Amico (Alden Medical)
Research collaborations: University of Washington · Cardiff Metropolitan University.
Partnerships, licensing, distribution, and enterprise deployment — we’d like to hear from you.
Get in touch →